Correlation Between Cns Pharmaceuticals and Neximmune

Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and Neximmune at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and Neximmune into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cns Pharmaceuticals and Neximmune, you can compare the effects of market volatilities on Cns Pharmaceuticals and Neximmune and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of Neximmune. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and Neximmune.

Diversification Opportunities for Cns Pharmaceuticals and Neximmune

0.41

Correlation Coefficient

Cns Pharmaceuticals  Neximmune

Very weak diversification

The 3 months correlation between Cns and Neximmune is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and Neximmune in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neximmune and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with Neximmune. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neximmune has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and Neximmune go up and down completely randomly.

Pair Corralation between Cns Pharmaceuticals and Neximmune

Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the Neximmune. In addition to that, Cns Pharmaceuticals is 1.03 times more volatile than Neximmune. It trades about -0.23 of its total potential returns per unit of risk. Neximmune is currently generating about -0.01 per unit of volatility. If you would invest  328.00  in Neximmune on July 26, 2024 and sell it today you would lose (85.00) from holding Neximmune or give up 25.91% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	44.35%
Values	Daily Returns

Cns Pharmaceuticals  vs.  Neximmune

Cns Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cns Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in November 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Neximmune

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neximmune has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Neximmune is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with Cns Pharmaceuticals and Neximmune

The main advantage of trading using opposite Cns Pharmaceuticals and Neximmune positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, Neximmune can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neximmune will offset losses from the drop in Neximmune's long position.

The idea behind Cns Pharmaceuticals and Neximmune pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..